Emil D. Kakkis

2014

In 2014, Emil D. Kakkis earned a total compensation of $699K as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$175,000
Salary$496,867
Other$27,163
Total$699,030

Kakkis received $496.9K in salary, accounting for 71% of the total pay in 2014.

Kakkis also received $175K in non-equity incentive plan and $27.2K in other compensation.

Rankings

In 2014, Emil D. Kakkis' compensation ranked 9,056th out of 13,032 executives tracked by ExecPay. In other words, Kakkis earned more than 30.5% of executives.

ClassificationRankingPercentile
All
9,056
out of 13,032
31st
Division
Manufacturing
3,391
out of 4,965
32nd
Major group
Chemicals And Allied Products
1,151
out of 1,690
32nd
Industry group
Drugs
912
out of 1,369
33rd
Industry
Pharmaceutical Preparations
697
out of 1,042
33rd
Source: SEC filing on April 28, 2017.

Kakkis' colleagues

We found three more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2014.

2014

Sunil Agarwal

Ultragenyx Pharmaceutical

Chief Medical Officer

2014

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

2014

Thomas Kassberg

Ultragenyx Pharmaceutical

Senior Vice President and Chief Business Officer

News

You may also like